Perceptive Advisors’s Grace Therapeutics, Inc. Common Stock GRCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q1
Sell
-37,081
Closed -$4.36M 125
2019
Q4
$4.36M Hold
37,081
0.09% 80
2019
Q3
$3.36M Hold
37,081
0.09% 79
2019
Q2
$2.03M Hold
37,081
0.05% 84
2019
Q1
$1.82M Hold
37,081
0.05% 77
2018
Q4
$1.48M Buy
+37,081
New +$1.48M 0.06% 76
2018
Q3
Sell
-4,306
Closed -$117K 134
2018
Q2
$117K Buy
4,306
+419
+11% +$11.4K ﹤0.01% 122
2018
Q1
$190K Hold
3,887
0.01% 124
2017
Q4
$176K Hold
3,887
0.01% 128
2017
Q3
$267K Hold
3,887
0.01% 130
2017
Q2
$247K Hold
3,887
0.01% 116
2017
Q1
$254K Hold
3,887
0.01% 128
2016
Q4
$233K Sell
3,887
-1,041
-21% -$62.4K 0.02% 135
2016
Q3
$414K Hold
4,928
0.03% 141
2016
Q2
$336K Hold
4,928
0.02% 127
2016
Q1
$360K Hold
4,928
0.03% 135
2015
Q4
$594K Hold
4,928
0.04% 92
2015
Q3
$626K Hold
4,928
0.05% 93
2015
Q2
$745K Hold
4,928
0.04% 114
2015
Q1
$1.13M Sell
4,928
-434
-8% -$99.9K 0.09% 92
2014
Q4
$1.29M Hold
5,362
0.11% 90
2014
Q3
$1.98M Buy
5,362
+15
+0.3% +$5.55K 0.2% 63
2014
Q2
$2.44M Sell
5,347
-631
-11% -$288K 0.24% 55
2014
Q1
$3.3M Sell
5,978
-3,167
-35% -$1.75M 0.35% 51
2013
Q4
$5.24M Buy
9,145
+8,823
+2,740% +$5.05M 0.63% 35
2013
Q3
$366K Buy
+322
New +$366K 0.03% 65